Ryzodeg® Penfill® 100 Units/mL – Insulin Degludec / Insulin Aspart
Advanced Diabetes Management
Ryzodeg® Penfill® 100 Units/mL is a prescription insulin medication manufactured by Novo Nordisk, designed to help manage blood sugar levels in people with diabetes mellitus. It combines two types of insulin—70% Insulin Degludec (long-acting) and 30% Insulin Aspart (rapid-acting)—to provide both basal and mealtime insulin coverage in a single formulation.
Key Benefits
1. Effective Blood Sugar Control
Helps regulate blood glucose levels in patients with diabetes by providing both long-acting and rapid-acting insulin effects.
2. Dual-Action Insulin Formula
Combines Insulin Degludec for sustained background insulin coverage and Insulin Aspart to manage blood sugar increases associated with meals.
3. Convenient Insulin Administration
Available in 3 mL cartridges designed for use with compatible reusable insulin pens, supporting convenient and accurate prescribed dosing.
4. Long-Lasting Insulin Coverage
Provides sustained basal insulin activity alongside rapid-acting mealtime insulin to support comprehensive diabetes management.
Product Information
Product Name: Ryzodeg® Penfill®
Manufacturer: Novo Nordisk
Composition: Insulin Degludec 70% + Insulin Aspart 30%
Strength: 100 Units/mL
Pack Size: 5 × 3 mL Cartridges
Administration: Subcutaneous Injection
Category: Diabetes Care / Insulin
Prescription Required: Yes
Storage Instructions
Store unopened cartridges in a refrigerator at 2°C–8°C. Do not freeze. Protect from excessive heat and direct sunlight. Follow the manufacturer's instructions for storage after first use.
Important Safety Information
Ryzodeg® Penfill® should only be used under medical supervision and with a valid prescription. Dosage and administration must be determined by a qualified healthcare professional. Incorrect insulin dosing can cause hypoglycemia (low blood sugar).
Note: This product is intended for prescription-based diabetes management. Always follow your healthcare provider's instructions.
